Organon (OGN) closed the most recent trading day at $6.23, moving -2.5% from the previous trading session. This move lagged the S&P 500's daily loss of 1.36%. Meanwhile, the Dow experienced a drop of ...

Organon (OGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Shares of Organon (OGN) slipped 1% to close at $6.47 on Tuesday, adding to six straight sessions of decline. The stock has fallen around 9.2% between March 2 and March 9, compared to a 1.24% decline ...

This protocol uses Reprogrammable Adenosine Deaminase Acting on RNA (ADAR) Sensors (RADARS) to robustly sense RNA transcripts inside eukaryotic cells, enabling detection of changes in gene expression ...

Sio initiated a new OGN position in the fourth quarter, buying up 3,421,765 shares. The quarter-end position value increased by $24.53 million as a result. The Organon holding now accounts for 4% of ...

Organon is an American pharmaceutical company spun off from Merck & Co. in 2021 with a focus on women's health, biosimilars, and established brands. Headquartered in Jersey City, it markets a ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.